Human N-acetylglucosamine-6-sulphate sulphatase was purified at least 50000-fold to homogeneity in 780%
INTRODUCTION
The sulphated glycosaminoglycan heparan sulphate is degraded from its non-reducing end by the sequential action of at least nine different lysosomal exo-enzyme activities [1,21. The clinical expression of the Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III), which classically presents with progressive mental retardation in conjunction with mild skeletal deformities, is a result of a deficiency of any one of four of these nine different enzyme activities, leading to the accumulation of partially degraded heparan sulphate in tissues and its excretion in urine [3] . The de-O-sulphation of nonreducing terminal N-acetylglucosamine 6-sulphate (GlcNAc6S) residues in heparan sulphate requires a specific exo-sulphatase, namely N-acetylglucosamine-6-sulphate sulphatase (6SS), which has been shown to be deficient in Sanfilippo D (MPS IIID) patients [4] .
We have previously shown in cultured human skin fibroblasts that the same 6SS enzyme activity will act upon non-reducing terminal GlcNAc6S present in both heparan sulphate [linked a-(1-> 4) to a uronic acid residue] and keratan sulphate [linked p-(l -* 3) to a galactose residue] [5] . Keratan sulphate is not detected in the urine of MPS IIID patients because of an alternative pathway of degradation, which probably proceeds by the action of the A form of ,J-N-acetylglucosaminidase to produce GlcNAc6S, which is not further degraded and is found in urine from these patients [6] [7] [8] .
A single form of 6SS with activity towards GlcNAc6S at the non-reducing terminal of a heparan sulphatederived trisaccharide has been purified 136-fold from human urine with a recovery of 1 % enzyme activity and shown to have a molecular mass of 97 kDa [9] . Habuchi et al. [10] have reported 6SS activity in rat skin towards GlcNAc6S residues at the non-reducing end of heparan sulphate-and keratan sulphate-derived substrates with a molecular mass of 70 kDa. Evidence of a sulphatase activity towards non-reducing terminal 2-sulphaminoglucosamine 6-sulphate residues in heparan sulphate distinct from activity towards GlcNAc6S residues has been reported to be present in bovine kidney extracts [11] . Resolution of questions raised in these studies [5] [6] [7] [8] [9] [10] [11] about the physical properties and substrate-specificity of 6SS requires the purification of this low-abundance protein to homogeneity in high yields. We now report the purification to homogeneity of two major forms of 6SS from human liver, both with native molecular masses of Vol. 246 Abbreviations used (for simplicity IdOA 75 kDa, purified 57000-fold with a recovery of 78% enzyme activity. Two lower-abundance forms have also been partially purified. Enzyme activity was towards an easily prepared 3H-labelled disaccharide substrate derived from heparin. [5] . Fibroblast cultures were established from skin biopsies taken in or provided to this hospital. MPS IIID fibroblasts were obtained from a patient excreting excessive amounts of heparan sulphate and with deficient 6SS activity in leucocytes and cultured fibroblasts [6] . Preparation of 6SS substrates (GlcNAc6S-IdOA and GlcNS6S-IdOA)
MATERIALS AND METHODS
A disaccharide fraction was prepared by mild HCI hydrolysis of cetylpyridinium chloride-precipitated heparin [12, 13] . This disaccharide has been shown, subsequent to reduction with NaB3H4, to consist of a mixture of glucosamine linked c-(1 -*3) to idonic acid, gulonic acid or anhydroidonic acid in the proportions 12:3:5 respectively [12] . The mixture was utilized without separation into its components. The non-reduced disaccharide fraction was 6-sulphated by an adaptation of published methods under conditions that favour sulphation of the primary alcohol groups [14] [15] [16] [17] . The formation of the 6-sulphated monosaccharides occurs after reaction at 4 'C. Multiple sulphation occurs if the reaction is allowed to reach room temperature. Glucosamine or galactosamine, however, could not be 0-sulphated by this or other direct sulphation methods.
A suggested reason for this difficulty was that the reaction between the free amino and aldehyde groups would lead to the formation of polymers [18] . However, as shown below, it is possible to 0-sulphate the above heparin-derived disaccharides directly.
A 5 ml portion of pyridine (dried over type 3A molecular sieves) was added to the desalted and freeze-dried disaccharide (7.4 mg, 21 /tmol), and the mixture was rotary-evaporated to dryness in a pearshaped flask. This procedure was repeated twice, before 5 ml of dry pyridine, 10 ml of dry dimethylformamide and approx. 50 mg of type 3A molecular-sieve powder were added and the stoppered flask was chilled in an ice bath. Chlorosulphonic acid (1501,, 2 mmol) in dried redistilled chloroform (150 ll) was added in three equal portions over 10 min, and the mixture was stirred at 0°C for 1 h and then at room temperature (22°C) for a further 1 h. Next 10 ml of water was added, the mixture was centrifuged at 2000 g for 10 min and the supernatant was neutralized with 1 M-NaOH and rotary-evaporated to dryness. Then 20 ml of water was added, and the solution was neutralized and applied to a 5 ml column of Dowex 1 (Cl-form), which was washed with 50 ml of water and then with 20 ml of 1 M-LiCl. The LiCl eluate was concentrated to 4 ml by rotary evaporation and desalted on a Sephadex G-10 column (100 cm x 1 cm diam.) developed in 10% (v/v) ethanol in water. The uronic acid-positive fractions, determined by the method of Bitter & Muir [19] , were pooled and concentrated to 1 ml by rotary evaporation, 50,l of 1 M-BaCl2 was added and the precipitate (BaSO4) was removed by centrifugation, and the procedure was repeated until a precipitate was no longer observed. The supernatant was applied to a 2 ml column of Dowex 50 (H+ form) and washed with 10 ml of water, and the eluate was concentrated and then desalted on a Sephadex G-10 column, as described above, to give a 6-sulphated disaccharide mixture (2.8 mg, 8 ,tmol) in 38% yield on recovered uronic acid. The freeze-dried 6-sulphated disaccharides were radiolabelled by reduction with 100 ,tCi of NaB3H4 (10 Ci/mmol) by a method described [13] to give a disaccharide mixture consisting
abbreviated GlcNH6S-IdOA) with a specific radioactivity of 10 Ci/mmol of uronic acid. GlcNH6S-IdOA was N-acetylated [15] and purified by preparative highvoltage electrophoresis on Whatman 3MM chromatography paper in 1.74 M-formic acid, pH 1.7, at 45 V/cm for 40 min in a Shandon Southern model L-24 system (Shandon Southern Products, Runcorn, Cheshire, U.K.). Areas of radioactivity at approx. 12 cm towards the anode from the origin, detected with a Packard model 7201 radiochromatogram scanner (Packard Instruments, Chicago, IL, U.S.A.), were eluted from the strip in 10%
(v/v) ethanol in water. The eluate was freeze-dried and reconstituted in 10% (v/v) ethanol of water to give the substrate GlcNAc6S-IdOA. GlcNAc6S-IdOA was also prepared by 6-sulphation of the N-acetylated disaccharide fraction from heparin and then reduction. GlcNH6S-IdOA was N-sulphated [15] and purified by preparative high-voltage electrophoresis (as above) to yield GlcNS6S-IdOA. GlcNAc6S-IdOA was completely desulphated by incubation with cultured human skin fibroblast homogenates, but there was no detected hydrolysis with homogenates of skin fibroblasts derived from an MPS IIID patient. These results, taken with the Fractions indicated were assayed for 6SS activity (@) and protein (0).
further characterization of the initial disaccharide [12, 13] , are very strong evidence in support of the GlcNAc6S-IdOA structure proposed for this substrate. Care was taken to remove free sulphate by precipitation with BaCl2, as the 6SS activity towards the disaccharide substrate is 50% inhibited by 30 ,uM-Na2SO4. GlcNS6S-IdOA and GlcNAc6S-Galitol were also used as substrates for 6SS. However, since GlcNS6S-IdOA and GlcNAc6S-Galitol are also hydrolysed by sulphamate sulphohydrolase and ,-N-acetylhexosaminidase respectively [5, 13] , they were only used in preliminary studies of enzyme substrate-specificity with purified forms A, B, C or D. 6SS enzyme assay GlcNAc6S-IdOA was routinely used to monitor 6SS activities specifically in all the purification steps outlined below.
The standard assay mixture contained 1 pAl of enzyme solution [dialysed against 20 mM-Tris/HCl buffer, pH 7.2, containing 10% (v/v) glycerol, 0.5 M-NaCl and 0.1 mM-dithioerythritol], 0.2 nmol of GlcNAc6S-IdOA, and bovine serum albumin (50 ,ug/ml) in 60 mM-sodium acetate buffer, pH 5.0, in a total volume of 20 1,. The mixture was incubated at 37°C for a time interval varying from 10 min to 12 h to give between 5 and 20% breakdown of substrate to product. Fibroblast 6SS was assayed by using the above incubation mixture with added fibroblast homogenate prepared [5] and adjusted to give a total of 10 ,g of protein per incubation. Reactions were stopped by freezing in a solid-C02/ethanol bath and the substrate was separated from the product by high-voltage electrophoresis on Whatman 3MM chromatography paper in 1.74 M-formic acid, pH 1.7. Areas of radioactivity were cut from the strip, placed in 20 ml glass scintillation vials along with 5 ml of water and 10 ml of scintillation cocktail and their radioactivities determined in an Isocap 300 liquidscintillation system (Searle Analytic, Des Plaines, IL, U.S.A.) with a counting efficiency of 19%. Enzyme activity was determined from the percentage breakdown of substrate to product and expressed as nmol/min per mg of protein or pmol/min per ,l of enzyme.
The pH-enzyme activity profile was determined by using the standard assay mixture in 60 mM-sodium acetate varying in pH from 3.0 to 6.8. Km and Vmax values were obtained from Lineweaver-Burk plots with a GlcNAc6S-IdOA concentration range of 1-100 ,UM.
Purification of 6SS
All procedures were performed at 4°C and all buffers contained 10% (v/v) glycerol and 0.1 mM-dithioerythritol.
Step 1. Concanavalin A-Sepharose/Blue A-agarose chromatography. Preparation of liver (0.8 kg) homogenate and high-speed supernatant was as described elsewhere [21, 22] and modified as in ref. [23] . The joined columns were washed with 2 litres of 15 mM-sodium dimethylglutarate buffer, pH 6.0, containing 0.5 M-NaCl (buffer A). This was combined with the reservoir (methyl z-mannoside recycling) buffer, and concentrated to approx. 200 ml in a hollow-fibre Amicon DC-2 concentrator and the volume reduced further to approx. 40 ml in an Amicon ultrafiltration stirred cell (model 8200) containing a YM10 membrane. For convenience concentrates from three separate 0.8 kg liver preparations, which had been stored at 4°C for no longer than 3 weeks, were pooled for use in step 2.
Step 2. Chromatofocusing chromatography (Fig. 1) . The concentrated enzyme solution was dialysed overnight against 2 litres of 30 mM-Tris/HCl buffer, pH 7.4, and applied to a PBE 94 chromatofocusing column (45 cm x 1.5 cm diam.) equilibrated in the same buffer. The column was washed with 150 ml of the same buffer, and this was combined with the flow-through material (obtained from the sample application) for further processing in Step 3. Application of 600 ml of a 1-in-18 dilution of Polybuffer 74/HCI, pH 4.0, eluted more 6SS activity with peak activity at pH 5.8 (form C) and pH 5.4 (form D). Further purification of form C is described in steps 5 and 6 below.
Step 3. Cu2+-chelating Sepharose chromatography (Fig. 2) . Chelating Sepharose, in a column (10 cm x I cm Vol. 246 diam.), was complexed with Cu2+ ions and equilibrated in buffer A adjusted to pH 6.7. The unbound fraction from the chromatofocusing step was made 0.5 M in NaCl, concentrated to 20 ml, and dialysed in an ultrafiltration stirred cell against buffer A adjusted to pH 6.7 and applied to the Cu2+-chelating Sepharose column. The column was washed with 50 ml of the same buffer and the 6SS activity was eluted with 150 ml of buffer A adjusted to pH 5.7.
Step 4. Hydroxyapatite chromatography (Fig. 3) . The fractions from step 3 containing 6SS activity (Fig. 2) were pooled and concentrated to 20 ml, dialysed in an ultrafiltration stirred cell against 20 
Step 5. Gel-filtration chromatography of form C. Fractions containing form C (Fig. 1) were pooled, concentrated to 2 ml, dialysed against buffer A and applied to an Ultrogel AcA 34 column (80 cm x 2.5 cm diam.) equilibrated in the same buffer and eluted at a rate of 20 ml/h.
Step 6. Cu2 +-chelating Sepharose chromatography of form C. The fractions containing 6SS activity from step 5 were pooled, concentrated to 20 ml and dialysed against buffer A adjusted to pH 6.7, and the procedure outlined in step 3 was utilized.
Other enzyme activities Enzyme activity towards sulphamate sulphohydrolase [24] , a-L-iduronidase [23] , sulphoiduronate sulphohydrolase [25] , arylsulphatase B [26] , ,-N-acetylhexosaminidase [5] , ac-N-acetylglucosaminidase [27] , acetyl-CoA: glucosamine N-acetyltransferase [28] , ,-glucuronidase [29] and N-acetylgalactosamine-6-sulphate sulphatase [30] substrates were assayed by previously reported procedures.
Uptake of 6SS into enzyme-deficient fibroblasts
Fibroblasts from a MPS IIID patient were grown in culture as described previously [5] . Solutions of forms A and B (equivalent to 150 times the enzyme units present in an equivalent number of normal fibroblasts; 16 pmol/3 ml of medium per 50 ml culture bottle) in culture medium were sterilized by filtration and added to the culture flasks. Cultures of the cells were harvested at intervals over 48 h and washed thoroughly with 0.15 M-NaCl, and the 6SS activity in cell homogenates was determined by using GlcNAc6S-IdOA incubations as described above.
Gel-permeation chromatography
A column (80 cm x 2.5 cm diam.) of Ultrogel AcA 34 equilibrated in buffer A had a 2 ml sample of enzyme in the same buffer loaded and eluted at a flow rate of 20 ml/h. A column (83 cm x 2.5 cm diam.) of Fractogel TSK HW55(S) in buffer A was eluted at a flow rate of 60 ml/h. The columns were calibrated with the following molecular-mass-standard proteins: thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), fructose-bisphosphate aldolase (158 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen (25 kDa) and ribonuclease A (13 kDa). SDS/polyacrylamide-slab-gel electrophoresis Samples were prepared by using a deoxycholate/ trichloroacetic acid co-precipitation method [31] and, unless otherwise stated, reduced by boiling in dithioerythritol. Discontinuous SDS/polyacrylamide-gel electrophoresis was run according to the method of Laemmli [32] , stained with Coomassie Brilliant Blue R250 and with the silver staining method of Merril et al. [33] . Gels were calibrated with a low-molecular-mass electrophoresis calibration kit consisting of phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soya-bean trypsin inhibitor (20 kDa) and a-lactalbumin (14 kDa). 
RESULTS

Purification of 6SS
All 6SS activity was bound to concanavalin ASepharose, demonstrating the glycoprotein nature of the enzyme. However, 6SS did not bind to the Blue A-agarose following its elution with methyl a-mannoside from the lectin column. A total-of-162% 6SS activity was recovered in this step, representing a 212-fold purification.., with a 98% decrease in protein ( Table 1 ). The apparent increase in the total 6SS activity recovered at this stage may be due to the removal of a non-diffusible inhibitor.
The chromatofocusing step separated 6SS forms A and B, which did not bind to the column at pH 7.4, from forms C and D, which remained bound to the column along with 90% of the applied protein (Fig. 1) . After application of Polybuffer, 6SS activity was eluted in two broad peaks, at pH 5.8 (form C) and pH 5.4 (form D). Forms C and D comprised 10% of the total 6SS activity recovered from this step. The unbound forms (A plus B) did not bind if re-applied to a regenerated chromatofocusing column at pH 7.4 or at pH values up to 9.5, indicating that these forms had a pI greater than 9.5. The enzyme was unstable in buffer at higher than pH 9.5.
Application of the 6SS fractions from step 1 to a DEAE-Sepharose column at pH 7.4 and elution with a salt gradient gave a similar separation of forms to that observed with the chromatofocusing column (results not shown).
Chromatography of the chromatofocusing-column unbound fraction (forms A and B) on chelating Sepharose charged with Cu2+ resulted in separation of 6SS from all other proteins (Fig. 2) , including other lysosomal enzymes involved in glycosaminoglycan degradation (including no detectable activity of a-L-iduronidase, ,J-N-acetylglucosaminidase, sulphamate sulphohydrolase, arylsulphatase B, sulphoiduronate sulphohydrolase, a-N-acetylglucosaminidase, N-acetylgalactosamine-6-sulphate sulphatase, fl-glucuronidase and acetylCoA glucosamine N-acetyltransferase in the eluate) to give a final 57000-fold purification of 6SS containing both forms A and B with a 78% recovery of the total enzyme activity found in the original liver homogenate. SDS/polyacrylamide-gel-electrophoresis analysis revealed three Coomassie-Blue-stained bands at apparent molecular-mass values of 78, 48 and 32 kDa (Figs. 4 and  5) whether the samples were pretreated under reducing (with dithioerythritol) or non-reducing conditions. No other polypeptides were observed after staining with the more sensitive silver staining method of Merril et al. [33] . Two faint bands often observed on the gels at apparent molecular-mass values of60 and 54 kDa were attributable to dithioerythritol as described by Tasheva & Dessev [20] , and were present in the buffer blank as well as in all other samples that had been reduced with dithioerythritol.
The 6SS fraction from step 3 was separated into form A and form B by hydroxyapatite chromatography (Fig.  3 ). This step, in which the 6SS activity was spread over much of the profile, resulted in a considerable loss of activity, possibly from dilution of the enzyme. Phosphate (100 mM) and 1.5 M-NaCl washes of the hydroxyapatite column did not contain 6SS activity. Generally we have found hydroxyapatite chromatography of lysosomal enzymes to result in poor yields compared with other chromatography steps [21, 23] . Forms A and B have similar native molecular masses, but differ in SDS/polyacrylamide-gel-electrophoresis subunit composition (Fig.  4) . Form A, which was eluted at 0.32 M-NaCl, revealed a single band at molecular mass 78 kDa, whereas form B, which was eluted at 0.64 M-NaCl, contained 48 kDa and 32 kDa polypeptides when subjected to SDS/polyacrylamide-gel electrophoresis under reducing or nonreducing conditions. Pool 2 (Fig. 3) by SDS/polyacrylamide-gel electrophoresis appeared to be a mixture of forms A and B. Partial purification of form C Form C from the chromatofocusing column (Fig. 1) , when subjected to gel-permeation chromatography on Ultrogel AcA 34, was eluted with a molecular-mass value of 94 kDa. This step, beside removing other proteins, separated 6SS from the non-diffusible Polybuffer, which, if it remained, stripped Cu2+ from the Cu2+-chelating Sepharose during the next stage of purification. Form C was eluted from the Cu2+-chelating Sepharose column under conditions similar to those observed for forms A and B. These steps resulted in a 34000-fold purification of form C. SDS/polyacrylamide-gel-electrophoresis analysis revealed three major Coomassie-Blue-stained bands corresponding to molecular-mass values of 48, 45 and 32 kDa (Figs. 4 and 5) . Native molecular masses of forms A, B, C and D (Fig. 5 
DISCUSSION
We have purified 6SS from human liver by more than 55000-fold with a net recovery of at least 78% after the Cu2+-chelating Sepharose step. This is an extremely simple purification protocol utilizing a rapid threecolumn procedure that includes a combined concanavalin A-Sepharose/Blue A-agarose recycling step [9] . Partially purified rat skin 6SS had a molecular mass of 70 kDa and, although most activity did not bind to DEAEcellulose at pH 7.2, a small amount did bind and was eluted by a salt gradient, but was not further characterized [10] . These different physical properties for 6SS possibly reflect the different sources of enzyme and/or their relatively low recoveries, resulting in the selective isolation of one form over others that may be present in the initial tissue extract.
The presence of multiple forms of other lysosomal enzymes involved in the degradation of glycosaminoglycans {e.g. a-L-iduronidase [23] , arylsulphatase B [35, 36] , a-N-acetylglucosaminidase [37] , sulphoiduronate sulphohydrolase (J. Bielicki, P. R. Clements & J. J. Hopwood, unpublished work) and ,-N-acetylhexosaminidase [38] } or in the degradation of other glycoconjugates [39, 40] have been reported. Cheng et al. [40] purified and identified two forms of cx-D-mannosidase from human liver that differed in both their subunit composition and their ability to be taken up into cultured human skin fibroblasts. The major forms (A and B) of 6SS were not taken up by fibroblasts under similar conditions to those described by Cheng et al. [40] and to those in which we have been able to demonstrate uptake of arylsulphatase B and ac-L-iduronidase prepared from the same human livers (G. J. Gibson, P. R. Clements, C. Freeman activities towards substrates with either a-or fl-linked N-acetylglucosamine 6-sulphate or a-linked 2-sulphaminoglycosamine 6-sulphate non-reducing end residues. This aspect, together with the effect of aglycone structure on 6SS activity, has recently been studied in depth with the various enzyme forms described above [41] . 
